These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10083157)

  • 1. Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
    Fisher RA; Pan SH; Rossi SJ; Schroeder TJ; Irish WD; Canafax DM; Lopez RR
    Transplant Proc; 1999; 31(1-2):394-5. PubMed ID: 10083157
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.
    Gaston R; Alloway RR; Gaber AO; Rossi SJ; Schroeder TJ; Irish WD; Canafax DM; First MR
    Transplant Proc; 1999; 31(1-2):326-7. PubMed ID: 10083128
    [No Abstract]   [Full Text] [Related]  

  • 3. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
    Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
    Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
    Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
    Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
    [No Abstract]   [Full Text] [Related]  

  • 5. Conversion of stable renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
    First MR; Weiskittel P; Shah M; Peddi VR; Canafax D; Schroeder TJ
    Transplant Proc; 1998 Dec; 30(8):3955-7. PubMed ID: 9865260
    [No Abstract]   [Full Text] [Related]  

  • 6. Conversion from standard cyclosporine to Neoral in lung transplant recipients.
    Kesten S; Scavuzzo M; Laurin L; Tan A; Chaparro C
    Transplant Proc; 1998 Aug; 30(5):1895-7. PubMed ID: 9723324
    [No Abstract]   [Full Text] [Related]  

  • 7. Uses of Neoral in pediatric liver transplantation.
    McDiarmid SV
    Transplant Proc; 1996 Aug; 28(4):2264-6. PubMed ID: 8769220
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of cyclosporine pharmacokinetics to clinical outcomes after liver transplantation. Canadian Liver Transplant Study Group.
    Transplant Proc; 1998 Aug; 30(5):1826-7. PubMed ID: 9723297
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and tolerability of Neoral in transplant recipients.
    Feutren G; Wong R; Jin J; Niese D; Mellein B
    Transplant Proc; 1996 Aug; 28(4):2177-82. PubMed ID: 8769193
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
    Grant D; Rochon J; Levy G
    Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving the oral absorption of cyclosporine in malabsorbers: a review of the Neoral Compassionate Need Program.
    Mueller EA; Kovarik JM; Pittrow D
    Transplant Proc; 1998 Aug; 30(5):1691-3. PubMed ID: 9723246
    [No Abstract]   [Full Text] [Related]  

  • 12. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption.
    Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R
    Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral.
    Cantarovich M; Barkun J; Besner JG; Metrakos P; Alpert E; Deschénes M; Aalamian Z; Tchervenkov JI
    Transplant Proc; 1998 Jun; 30(4):1462-3. PubMed ID: 9636593
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of conversion from Sandimmune to Neoral on glomerular filtration rate in stable renal transplant recipients.
    Steinmuller D; Dougherty J; Coutee J; Surek D; Swies G; Lewis R
    Transplant Proc; 1997; 29(1-2):298-9. PubMed ID: 9123005
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
    Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
    Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
    Cooney GF; Lum BL; Meligeni JA; Dunn SP
    Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative pharmacokinetic study of Neoral vs Sandimmun in Japanese stable renal allograft recipients.
    Takahara S; Ohta K; Ohashi Y; Namii Y; Uchida K; Okuyama A; Kainuma H; Takagi H; Takahashi K; Morikawa H
    Transplant Proc; 1999 Nov; 31(7):3089-92. PubMed ID: 10610595
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative pharmacokinetic study of neoral versus Sandimmun in Japanese stable renal allograft recipients.
    Takahara S; Ohta K; Ohashi Y; Namii Y; Uchida K; Okuyama A; Kainuma H; Takagi H; Takahashi K; Morikawa H
    Transplant Proc; 2001 Jun; 33(4):2541-4. PubMed ID: 11406243
    [No Abstract]   [Full Text] [Related]  

  • 19. Changing stable heart transplant recipients from Sandimmune to Neoral.
    Dalrymple-Hay M; Meara M; Reynolds L; Backhouse L; Wright D; Holt D; Johnston A; Madden B; Murday A
    Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
    [No Abstract]   [Full Text] [Related]  

  • 20. A limited sampling strategy for the estimation of 12-hour SangCya and neoral AUCs in renal transplant recipients.
    Meier-Kriesche HU; Alloway R; Gaber AO; Canafax DM; Kaplan B
    J Clin Pharmacol; 1999 Feb; 39(2):166-71. PubMed ID: 11563409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.